World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
39035
World Ranking
7954
National Ranking
303

Neil Fleshner publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Neil Fleshner sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 984 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Neil Fleshner D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Neil Fleshner sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Neil Fleshner is affiliated with the Princess Margaret Cancer Centre in Canada. Their research primarily spans the field of Medicine with a substantive focus on Pulmonary and Respiratory Medicine, Surgery, Oncology, Cancer Research, and Molecular Biology.

The core areas of study for Fleshner encompass multiple aspects of oncology and urology. Main topics in their work include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Cancer, Lipids, and Metabolism, Radiopharmaceutical Chemistry and Applications, and Hormonal and Reproductive Studies.

Fleshner has contributed extensively to scientific literature, with recurrent publications in notable venues such as:

  • The Journal of Urology
  • Canadian Urological Association Journal
  • Journal of Clinical Oncology
  • European Urology
  • Urologic Oncology Seminars and Original Investigations

Among recent significant papers associated with their work are:

  • "Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA," 2020, Annals of Oncology
  • "Epidemiology and Prevention of Prostate Cancer," 2021, European Urology Oncology
  • "Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer," 2023, Journal of Clinical Oncology
  • "Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis," 2023, The Lancet Oncology
  • "Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial," 2021, Circulation

Fleshner's work is often collaborative, reflected in frequent partnerships with several co-authors, including:

  • Girish S. Kulkarni
  • Antonio Finelli
  • Alexandre R. Zlotta
  • Alejandro Berlín
  • Theodorus van der Kwast

Best Publications

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

    Michael J. Zelefsky;Steven A. Leibel;Paul Gaudin;Gerald J. Kutcher

  • Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

    M C Liu;G R Oxnard;E A Klein;C Swanton

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch

  • Sensitive tumour detection and classification using plasma cell-free DNA methylomes

    Shu Yi Shen;Rajat Singhania;Gordon Fehringer;Ankur Chakravarthy

  • Genomic hallmarks of localized, non-indolent prostate cancer

    Michael Fraser;Veronica Y. Sabelnykova;Takafumi N. Yamaguchi;Lawrence E. Heisler

  • Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer ☆

    Michael A.S. Jewett;Kamal Mattar;Joan Basiuk;Christopher G. Morash

  • Spatial genomic heterogeneity within localized, multifocal prostate cancer

    Paul C. Boutros;Paul C. Boutros;Michael Fraser;Nicholas J. Harding;Richard De Borja

  • Feasibility Study: Watchful Waiting For Localized Low To Intermediate Grade Prostate Carcinoma With Selective Delayed Intervention Based On Prostate Specific Antigen, Histological And/Or Clinical Progression

    Richard Choo;Laurence Klotz;Cyril Danjoux;Gerard C. Morton

  • Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

    Scott M. Lippman;Phyllis J. Goodman;Eric A. Klein;Howard L. Parnes

  • Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes

    Shabbir M.H. Alibhai;Minh Duong-Hua;Rinku Sutradhar;Neil E. Fleshner

  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

    David V. Conti;Burcu F. Darst;Lilit C. Moss;Edward J. Saunders

  • Epidemiology and Prevention of Prostate Cancer.

    Giorgio Gandaglia;Riccardo Leni;Freddie Bray;Neil Fleshner

  • Cancer-related fatigue and associated disability in post-treatment cancer survivors.

    Jennifer M. Jones;Karin Olson;Pamela Catton;Charles N. Catton

  • Correlation between Gleason Score of Needle Biopsy and Radical Prostatectomy Specimen: Accuracy and Clinical Implications

    Michael S. Cookson;Neil E. Fleshner;Scott M. Soloway;William R. Fair

  • Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With Diabetes

    David Margel;David R. Urbach;Lorraine L. Lipscombe;Chaim M. Bell

  • Prevalence of Prostate Cancer on Autopsy: Cross-Sectional Study on Unscreened Caucasian and Asian Men

    Alexandre R. Zlotta;Shin Egawa;Dmitry Pushkar;Alexander Govorov

  • Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic

    Girish S Kulkarni;Thomas Hermanns;Yanliang Wei;Bimal Bhindi

  • DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER

    M.J. Zelefsky;S.A. Leibel;P.B. Gaudin;G.J. Kutcher

Frequent Co-Authors

Antonio Finelli
Antonio Finelli University Health Network
Alexandre R. Zlotta
Alexandre R. Zlotta University Health Network
Michael A.S. Jewett
Michael A.S. Jewett University of Toronto
Theodorus H. van der Kwast
Theodorus H. van der Kwast University Health Network
Laurence Klotz
Laurence Klotz University of Toronto
John Trachtenberg
John Trachtenberg University of Toronto
Padraig Warde
Padraig Warde Princess Margaret Cancer Centre
Nathan Lawrentschuk
Nathan Lawrentschuk University of Melbourne
Robert G. Bristow
Robert G. Bristow University of Manchester
Andrew Evans
Andrew Evans University of Dundee

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring flexible educational routes is essential for those interested in healthcare or medicine in the USA. Numerous online programs let you advance your credentials while balancing work, family, or other obligations. Accelerated options, such as a 1 year dnp program online, are designed for current nurses aiming for leadership or advanced clinical roles in a fraction of the standard time.

Some prospective students are concerned about program rigor. For those seeking a smoother academic journey, easiest dnp programs help minimize stress while still meeting strict accreditation standards. If you are looking to enter the field more quickly, a 9 month lpn program may let you qualify for practical nursing positions in under a year.

Those interested in mental health specialization can benefit from the fastest pmhnp program, enabling rapid entry into the high-demand field of psychiatric-mental health care. These varied online pathways allow learners to customize their progression based on career goals, timeline, and personal needs.

Best Scientists Citing Neil Fleshner

Trending Scientists

Recently Published Articles